Industry Insights
A Smarter Way To Remove Host Cell Protein Contamination From Gene Therapies
Industry InsightIn this piece, Ejvind Mørtz and Todd Stawicki explain why it’s critical that gene therapy products are free of host cell proteins and how this can be ensured in the production process, so that these next-generation drugs can fulfil their potential as one-shot cures for a range of diseases, from rare genetic conditions to cancer.
Read More
A Conversation With Professor Josef Penninger on the Journey to a COVID-19 Therapeutic
Industry InsightThe ACE2 receptor has garnered significant attention for the wrong reasons over recent months. Could it point towards an exit route out of this pandemic? In an interview with Technology Networks, the renowned immunologist Professor Josef Penninger explains why he thinks so, and discusses the latest clinical data obtained from testing the soluble ACE2 receptor, APN01.
Read More
Using Organoids in the Study of Infectious Diseases
Industry InsightBy providing greater physiologic relevance and a species- or patient-specific test platform, organoids overcome many limitations of conventional 2D cultures and even live-animal disease models.
Read More
Tapping Into Information Locked in Our T Cells To Fight COVID-19
Industry InsightT cells are an important part of our immune memory and offer a wealth of valuable information about the way our bodies perceive and respond to pathogens. Learn how this information is being harnessed and applied in the fight against COVID-19.
Read More
Harnessing Human Skin Models for Drug Development
Industry InsightWe recently spoke with Pascal Descargues, CEO at Genoskin to learn more about the legal restrictions on animal testing and how human skin tissue can be used as an alternative.
Read More
Breaking Down Barriers in Proteomic-Based Drug Discovery
Industry InsightSomaLogic recently announced an agreement with the biopharmaceutical company Amgen that aims to advance Amgen's drug discovery and development programs through comprehensive proteomic profiling. We spoke with Roy Smythe to discover what barriers have been holding proteome analysis back, and how the collaboration with Amgen aims to change the landscape of drug discovery.
Read More
Progress in Stem Cell Therapy for Transplant, Stroke and ARDS Patients
Industry InsightTechnology Networks spoke with Gil Van Bokkelen, CEO of Athersys, to learn more about MultiStem and the main mechanisms of action the cells have on the body. Gil also discussed some of the additional indications that the cells are being investigated as potential therapies for, including ischemic stroke and acute respiratory distress syndrome (ARDS).
Read More
CRISPR: Tips and Tricks for Efficient Delivery Into Primary Cells and Cell Lines
Industry InsightThis article provides tips and tricks for efficient delivery of CRISPR genome editing technology into primary cells and cell lines.
Read More
"Technology Dance" Looks Set To Transform the Field of DNA Synthesis
Industry InsightCodexis and Molecular Assemblies recently announced a partnership through which the companies aim to engineer enzymes that will optimize the process of enzymatic DNA synthesis – an alternative approach to chemical DNA synthesis. Technology Networks spoke with Codexis to find out how this will transform the field of DNA synthesis.
Read More
Decoding the Immune System
Industry InsightOur immune system is incredibly complex. Developing a complete understanding is an enormous undertaking but one to which scientists have been striving in order to advance disease understanding and improve treatments.
Read More
